Science

Another Bone to Pick with Merck

The pharmaceutical company Merck "paid an undisclosed sum to Elsevier to produce several volumes of a publication that had the look of a peer-reviewed medical journal, but contained only reprinted or summarized articles -- most of which presented data favorable to Merck products." The Australasian Journal of Bone and Joint Medicine carried "ads for Fosamax, a Merck drug for osteoporosis, and Vioxx" and "appeared to act solely as marketin

No

Climate Front Group Ignored Its Own Scientists

An internal document (pdf) of the Global Climate Coalition (GCC) -- an industry front group that disbanded in 2002 -- reveals that when the group chose to promote doubt about the reality of global warming it was ignoring the views of its own scientific a

No

Profiling the Global Warming Skeptics

The core of the small global network of global warming skeptics are once more gathering at a conference organized by the Heartland Institute, a corporate and foundation funded think tank based in Chicago.

Yes

Science Needs Permission?

"Biotechnology companies are keeping university scientists from fully researching the effectiveness and environmental impact of the industry’s genetically modified crops, according to an unusual complaint issued by a group of those scientists," reports Andrew Pollack.

No

This Is Your University, on Drugs

In 2002, an independent study on hormone replacement therapy was halted, because the drugs were strongly linked to an "increased risk for breast cancer, heart disease, stroke and blood clots" in women. The same year, the University of Wisconsin-Madison began offering an online course, "funded entirely by a $12 million grant from Wyeth Pharmaceuticals," that "promoted hormone therapy, touted its benefits and downplayed its risks." Wyeth makes two hormone therapy drugs, Prempro and Premarin.

No

How Big Tobacco Deals with Adverse Research -- and Researchers

A case study in the January issue of the American Journal of Public Health shows the extent to which the tobacco industry works to derail research -- and researchers -- that could adversely affect it.

No

How Wyeth Bought Science that Sells

According to internal documents, the pharmaceutical company Wyeth "paid ghostwriters to produce medical journal articles favorable to its female hormone replacement therapy Prempro." As early as 1997, Wyeth paid the "medical writing firm" DesignWrite to publish favorable journal articles about Prempro under academics' names.

No

Pages

Subscribe to Science